UBS Maintains Buy on CVS Health, Lowers Price Target to $107
Benzinga Newsdesk 17 hours ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $118 to $107.
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $118 to $107.